EVOGENE LTD. Increase Decrease In Cash And Cash Equivalents
EVOGENE LTD. (EVGN) reported Increase Decrease In Cash And Cash Equivalents of -$2.35 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents · last filed 2026-03-26
| Period end | Increase Decrease In Cash And Cash Equivalents 6 month | Increase Decrease In Cash And Cash Equivalents 12 month |
|---|---|---|
| 2025-12-31 | -$2.35M 20-F · filed 2026-03-26 | |
| 2025-06-30 | -$6.90M 6-K · filed 2025-09-30 | |
| 2024-12-31 | -$5.47M 20-F · filed 2026-03-26 | |
| 2024-06-30 | -$11.29M 6-K · filed 2025-09-30 | |
| 2023-12-31 | -$8.21M 20-F · filed 2026-03-26 | |
| 2023-06-30 | -$8.75M 6-K · filed 2024-09-16 | |
| 2022-12-31 | -$3.35M 20-F · filed 2025-03-27 | |
| 2022-06-30 | -$3.46M 6-K · filed 2023-09-13 | |
| 2021-12-31 | -$13.90M 20-F · filed 2024-03-28 | |
| 2021-06-30 | -$3.47M 6-K · filed 2022-09-07 | |
| 2020-12-31 | $11.48M 20-F · filed 2023-03-30 | |
| 2020-06-30 | -$3.67M 6-K · filed 2021-08-31 | |
| 2019-12-31 | $28.94M 20-F · filed 2022-03-31 | |
| 2019-06-30 | $8.29M 6-K · filed 2020-09-15 | |
| 2018-12-31 | $2.38M 20-F · filed 2021-04-02 | |
| 2017-12-31 | $199.00K 20-F · filed 2020-04-27 | |
| 2016-12-31 | -$6.99M 20-F · filed 2019-04-29 | |
| 2015-12-31 | $5.01M 20-F · filed 2018-03-30 |